Fig. 6From: MicroRNA-365 alleviates morphine analgesic tolerance via the inactivation of the ERK/CREB signaling pathway by negatively targeting β-arrestin2GFAP protein expressions of rats in spinal cord tissues in each group after administration at day 7. Note: A, immunofluorescence staining of GFAP in each group; B, rate of GFAP positive expression area in each group; scale bar, 200 μm; N = 8; *, P < 0.05 compared with the control group; #, P < 0.05 compared with the morphine tolerance group; GFAP, glial fibrillary acidic protein; NC, negative controlBack to article page